Drug Information Association Logo
Corporate Tagline

A Regulatory Perspective of Biosimilars in Emerging Markets

Track:
Regulatory Affairs and Submissions

Day & Time:
June 25, 8:00AM - 9:30AM

Session Number:
212

Room Number:
253B

Level:
Intermediate

Type:
Session

Title:
A Regulatory Perspective of Biosimilars in Emerging Markets

Chair(s):
Linda F. Bowen, MS,RAC
Head of US Regulatory Policy and Intelligence
Sanofi, United States

Description:
With a number of innovator biologicals going off patent, biosimilars present a promising opportunity and a high market potential. However, unlike small molecules, which have known chemical structures, structure activity relationships and well-defined chemical synthesis processes, biosimilars are complex proteins requiring multistep multifaceted manufacturing processes. Hence the development of biosimilars presents unique and complex challenges which need to be strategically planned.

As pharmaceutical business interests spread to Latin America and the Asia Pacific regions, understanding aspects of the regulatory environment in those regions became a critical success factor. This session will provide high-level insight into the regulatory framework for biosimilar product development in key Latin America and Asia Pacific markets. There will be a discussion of a practical case study involving different marketed biosimilar formulations of a known innovator biological product and the practical implications thereof.

Learning Objective(s):
Identify the key regulatory instruments related to the development and approval of biosimilar products in key markets of the Latin America (Brazil, Argentina and Mexico) and Asia Pacific (India, China, Korea) regions; Recognize the similarities and differences in the regulatory requirements in these markets.

Presentation(s) & Speaker(s):
Biosimilar Regulatory Environment in the Asia Pacific Region
Sonica Sachdeva Batra, DrMed
Director, Medical and Scientific Affairs
Jubilant Clinsys Ltd., India

Biosimilar Regulatory Environment in Latin America
Oliver Cox, MSc
Consultant
PAREXEL International, United Kingdom

© 2013 DIA